Supply delays, rise in Covid-19 cases lead to Remdesivir shortage

​​In India, companies such as Cipla, Dr Reddy’s, Hetero, Mylan, Zydus Cadila and Jubilant have the licence to manufacture the drug. Each of these companies is estimated to manufacture 100,000 vials every month.
Source: The Economic Times - Category: Consumer Health News Source Type: news